Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Onconetix (ONCO) EBIT Margin (2023 - 2025)

Onconetix (ONCO) has disclosed EBIT Margin for 2 consecutive years, with 5981.28% as the latest value for Q4 2024.

  • On a quarterly basis, EBIT Margin fell 1767620.0% to 5981.28% in Q4 2024 year-over-year; TTM through Dec 2024 was 798.6%, a 696884.0% decrease, with the full-year FY2024 number at 1429.81%, up 6306428.0% from a year prior.
  • EBIT Margin was 5981.28% for Q4 2024 at Onconetix, down from 650.32% in the prior quarter.
  • In the past five years, EBIT Margin ranged from a high of 11694.91% in Q4 2023 to a low of 176362.79% in Q1 2023.